Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Phys Med. 2021 Jul 17;88:175–192. doi: 10.1016/j.ejmp.2021.07.005

Fig. 7.

Fig. 7.

(A) AuNPs + RT causes vascular disruption and boosts deliveiy of liposomes. (B) DE EID CT shows Lip-I in a sarcoma (ellipse). Lip-I served as surrogate for Doxil. (C) The combined therapy with RGD-AuNPs + RT and Doxil showed a significant growth delay (increase in tumor doubling times) compared to all other treatment groups.